AHMED NADIM 4
4 · Cullinan Therapeutics, Inc. · Filed Feb 27, 2025
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-02-25$8.53/sh−12,529$106,872→ 430,621 total
Footnotes (1)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.